Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
SKI2852
Cat. No.:
OB0425LY-250
Appearance:
Solid
Purity:
98.33%
Identity:
Confirmed by NMR and HPLC.
Size:
Add to basket
Product Overview
Description:
SKI285 2is a potent non-steroidal 11β-hydroxydehydrogenase 1 (11β-HSD1) inhibitor that regulates glucose metabolism and improves insulin sensitivity.
Synonyms:
SKI2852; 1346554-47-9; 2-((R)-4-(2-Fluoro-4-(methylsulfonyl)phenyl)-2-methylpiperazin-1-yl)-N-((1R,2S,3S,5S,7S)-5-hydroxyadamantan-2-yl)pyrimidine-4-carboxamide
CAS No.:
1346554-47-9
Compound CID:
135905445
Formula:
C27H34FN5O4S
Formula Weight:
543.65
Specification
Target:
11β-HSD
Pathway:
Metabolic enzyme/Protease
Storage:
Storage at -20°C.
Applications:
SKI2852 is primarily used to explore its potential effects in the treatment of diabetes and related metabolic diseases.
